COPENHAGEN — Pharmacists are a trusted gateway to self-care and play an essential role in empowering people to manage their own health more effectively, according to a new Statement of Policy published by the International Pharmaceutical Federation (FIP) today. Updating FIP’s 2017 policy on self-care, the statement calls on governments, healthcare systems and pharmacy organisations to recognise, support and invest in the unique position pharmacists hold in helping individuals take charge of their health.
“Self-care is the foundation of healthier lives and societies, but people need support to do it well. Pharmacists are among the most accessible healthcare professionals worldwide — trusted, knowledgeable and part of their communities,” said Mr Luís Lourenço, FIP professional secretary and chair of the policy committee. “This policy reinforces pharmacists’ responsibility to inform, guide and support individuals in caring for themselves safely and effectively.”
The statement highlights how self-care, when properly supported, can help prevent illness, manage long-term conditions, reduce unnecessary doctor visits and hospital admissions, and lower overall healthcare costs. Pharmacists’ unique accessibility and health expertise bridge the gap between public health initiatives and the personal choices people make every day.
From providing advice on over-the-counter medicines, screening and point-of-care testing, to supporting healthy habits, vaccination and health literacy, pharmacists help individuals make informed decisions and build confidence in managing their wellbeing — especially in rural or underserved areas where they may be the only accessible healthcare professional.
Recognising this value, FIP’s updated policy includes clear recommendations for governments, insurers, pharmacy organisations and educators to strengthen pharmacist-led self-care services. These include fair remuneration, investment in community pharmacies, access to reliable health information, and support for pharmacists to expand their roles in prevention, education and public health promotion. The statement also outlines how pharmacy organisations and academic institutions should promote evidence-based practice, data collection and training.
“Pharmacists empower people to look after their health, but they can’t do it alone. Governments, insurers and the pharmaceutical industry must work together to ensure equitable access to self-care support and safe products — and that pharmacists are fully integrated into health systems to deliver these services,” Mr Lourenço added.
Through this statement, FIP commits to advocating globally for pharmacists’ essential role in self-care, providing leadership and guidance to its member organisations, and working with other healthcare professionals and the pharmaceutical industry to promote responsible, effective self-care practices.
FIP calls for greater recognition of pharmacists’ role in supporting self-care
Pharmacists’ unique accessibility and health expertise bridge the gap between public health initiatives and the personal choices people make every day.
Latest
North America leads rapidly growing GLP-1 market
The US drives growth via branded therapies, rising obesity, and broader use in diabetes and weight management.
L’Oréal and OpenAI expand partnership to transform beauty through AI
“At L’Oréal, we believe we can be more demanding of AI to augment our beauty consumers, our metiers such as Marketing and Research and our employees,” said Asmita Dubey, Chief Digital and Marketing Officer at L’Oréal.
Lupin launches generic Azilsartan Medoxomil tablets in U.S.
Lupin has launched Azilsartan Medoxomil Tablets, the generic version of Edarbi, for the treatment of hypertension and will receive 180 days of market exclusivity as the first-to-file applicant.
OCuSOFT introduces Retaine Ultra PF
"With Retaine Ultra PF, we are expanding our portfolio with a multi-dose option that combines convenience, accessibility, and value."